Recursion · 4 months ago
Global Head, Oncology Development
New York, New York
Full-time
Onsite
Director/Executive
$344K/yr - $414K/yrRecursion Pharmaceuticals is a clinical stage TechBio company focused on improving lives through advanced biological and chemical research. They are looking for a Global Head of Oncology Development to lead the oncology strategy, ensuring effective clinical plans and governance while integrating innovative technologies to optimize drug development.
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
Responsibilities
Provide significant input on clinical plans, trial design, clinical trial execution, medical governance, at a program level, and ensure appropriate and adequate clinical resourcing
Define disease area strategies and priorities, ensure patient focus and robust evidence package to support successful filings, approvals and commercialization and patient access. Accountable for the ethical conduct of studies in the oncology portfolio
Operate as a single point of accountability for medical governance at the clinical level. Ensure adequate clinical oversight of clinical research initiatives and provide a global and objective viewpoint of safety and efficacy by cultivating and sustaining a culture of openness and transparency with patient wellbeing as the key driver in decision-making
Evaluate, integrate, and scale AI/ML tools to optimize trial design, enhance patient recruitment strategies, and drive real-time data analysis. Foster a deep partnership with data science teams to seamlessly embed real-world evidence, big data, and advanced analytics into clinical decision-making, ensuring smarter, faster, and more adaptive clinical development
Responsible for drafting and reviewing medical aspects of core study and regulatory documents (i.e., protocols, investigator brochures, INDs, briefing documents, etc.)
Manage and maintain strong, effective relationships with key external stakeholders and partners (i.e., Key Opinion Leaders and investigators, consultants, patient advocacy groups and other external clinical trial participants) to ensure that the primary goals of the clinical development programs are met
Responsible for exploring opportunities for simplification, ensuring that this area is as effective and as efficient as possible to get drugs to patients faster
Qualification
Required
MD with Board Certification (or equivalent) in Medical Oncology or related Oncology Specialty; MD/PhD preferred
Considerable pharmaceutical industry experience and a track record of accomplishments is required
Experience working on innovative oncology programs that leverage a strong understanding of digital transformation, clinical trial technologies, and data science, including AI/ML applications in clinical development
Understands the entirety of R&D across the development/commercial life cycle to allow impact across all functions: discovery, late-stage development, regulatory, manufacturing, and commercial
Track record of success working in complex, matrixed, global, and multi-disciplinary organizations with high accountability and multiple lines of reporting
Proven ability to strategize, prioritize, and manage multiple projects simultaneously to ensure quality, timely, on-target, and within-budget accomplishment of tasks
Attention to detail while discriminating between critical and non-critical activities and following established processes while identifying areas for process improvement
Highly developed ethics and integrity, with demonstrated ethical medical decision-making skills
Benefits
Annual bonus
Equity compensation
Comprehensive benefits package
Company
Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.
Founded in 2013
501-1000 employees
H1B Sponsorship
Recursion has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (5)
2022 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$865.38MKey Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M
Leadership Team
Chris Gibson
Co-Founder and Chairman
Ben Mabey
Chief Technology Officer
Recent News
MenloVentures
2025-12-31
Hartford Business Journal
2025-12-30
felicis.com
2025-12-29
Company data provided by crunchbase